Congestive Heart Failure News and Research

RSS
Congestive Heart Failure is a condition in which the heart can't pump blood the way it should. In some cases, the heart can't fill with enough blood. In other cases, the heart can't send blood to the rest of the body with enough force. Some people have both problems. "Heart failure" doesn't mean that your heart has stopped or is about to stop working. However, it's a serious condition that requires medical care. Heart failure develops over time as the pumping of the heart grows weaker. It can affect the right side of the heart only or both the left and right sides of the heart. Most cases involve both sides of the heart.
Caltech researcher explores link between variable heart rate, health and fitness

Caltech researcher explores link between variable heart rate, health and fitness

Medicare experiment shows initial promise

Medicare experiment shows initial promise

RT with concurrent chemotherapy post surgery is effective for treating endometrial cancer

RT with concurrent chemotherapy post surgery is effective for treating endometrial cancer

New iodine-based contrast material enhances CT images to safely use in most patients

New iodine-based contrast material enhances CT images to safely use in most patients

Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

Viewpoints: Medicare no longer 'busting' the budget; a 'nightmare' trying to get coverage in D.C.

Viewpoints: Medicare no longer 'busting' the budget; a 'nightmare' trying to get coverage in D.C.

New wireless monitoring sensor helps doctors and patients manage heart failure problems

New wireless monitoring sensor helps doctors and patients manage heart failure problems

Researchers identify predictors of early rehospitalization among patients with COPD

Researchers identify predictors of early rehospitalization among patients with COPD

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Household income plays key role in avoidable hospital visits across New Jersey

Household income plays key role in avoidable hospital visits across New Jersey

Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF

Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF

Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

PAH disease burden ‘significant’

PAH disease burden ‘significant’

Mercy Memorial Hospital System signs LOI to join Promedica

Mercy Memorial Hospital System signs LOI to join Promedica

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

Poll: 5 percent of 2013 uninsured now have coverage

Poll: 5 percent of 2013 uninsured now have coverage

Six essential screening tests all men should receive during lifetime

Six essential screening tests all men should receive during lifetime

Risk factors for hospital readmissions identified in stroke patients

Risk factors for hospital readmissions identified in stroke patients

iGetBetter selects Validic platform to access data from broad range of biometric devices

iGetBetter selects Validic platform to access data from broad range of biometric devices

PointRight releases PointRight Pro 30 to track and reduce rehospitalization rates

PointRight releases PointRight Pro 30 to track and reduce rehospitalization rates

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.